I dont follow his Dexcom anymore and I certainly dont think it makes sense to follow when Im hundreds of miles away
Clinical studies indicate that patients can achieve a significant reduction in body weight, often between 10% to 15% of their initial weight, over approximately 68 weeks
This review synthesizes current evidence regarding SGLT2 inhibitors and GLP-1 receptor agonists in DKD, examines their mechanisms and clinical outcomes, and highlights future research directions to address ongoing therapeutic needs
The findings are intriguing because they align with what weve seen in preclinical models and some human studies: GLP-1RAs appear to reduce neuroinflammation, improve insulin signaling in the brain, and potentially slow processes associated with cognitive decline, he noted
Dosage and Duration: Doctors may adjust the dose to manage side effects or increase effectiveness
Williams and Ro will lead a multi-year campaign to normalize the use of GLP-1 medications for weight loss and support others on their health journeys